Clinical Trial Update: Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness [Phase 4]

View source ↗

Summary

Phase 4 trial update examining how long inhaled ipratropium bromide protects against methacholine-induced airway hyperresponsiveness in asthma; study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Atrovent (ipratropium bromide)
• IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)

Snippet

Sponsor: University of Saskatchewan | Conditions: Asthma | Phase 4 | Status: COMPLETED